Patents by Inventor Ignacio Moriyon

Ignacio Moriyon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified gram-negative bacteria for use as vaccines
    Patent number: 9034630
    Abstract: The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: May 19, 2015
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique—CNRS, Université d'Aix Marseille, UNIVERSIDAD DE NAVARRA
    Inventors: Jean-Pierre Gorvel, Vilma Arce Gorvel, Maite Iriarte, Ignacio Moriyon, Raquel Conde-Alvarez
  • Modified Gram-Negative Bacteria For Use As Vaccines
    Publication number: 20140286996
    Abstract: The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host.
    Type: Application
    Filed: June 5, 2014
    Publication date: September 25, 2014
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique - CNRS, Universite de la Mediterranee - Aix-Marseille II, Universidad de Navarra
    Inventors: Jean-Pierre Gorvel, Vilma Arce Gorvel, Maite Iriarte, Ignacio Moriyon, Raquel Conde-Alvarez
  • Modified gram-negative bacteria for use as vaccines
    Patent number: 8778655
    Abstract: The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: July 15, 2014
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique—CNRS, Universite de la Mediterranee—Aix-Marseille II, Universidad de Navarra
    Inventors: Jean-Pierre Gorvel, Vilma Arce Gorvel, Maite Iriarte, Ignacio Moriyon, Raquel Conde-Alvarez
  • MODIFIED GRAM-NEGATIVE BACTERIA FOR USE AS VACCINES
    Publication number: 20120183576
    Abstract: The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host.
    Type: Application
    Filed: September 21, 2010
    Publication date: July 19, 2012
    Inventors: Jean-Pierre Gorvel, Vilma Arce Gorvel, Maite Iriarte, Ignacio Moriyon, Raquel Conde-Alvarez
  • Antimicrobial peptides
    Patent number: 7960339
    Abstract: The present invention relates to families of polypeptides and lipopolypeptides that have antimicrobial and endotoxin-neutralizing activities. These molecules show a broad spectrum of activity against various pathogens (including bacteria, viruses, fungi etc.) These compounds can be used alone or in combination therapy with conventional antibiotics or antiendotoxic agents. In addition, the present invention discloses processes for making and using of the compounds.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: June 14, 2011
    Assignee: Österreichische Akademie der Wissenschaften
    Inventors: Sylvie E. Blondelle, Roman Jerala, Primoz Pristovsek, Andreja Majerle, Mateja Zorko, Bostjan Japelj, Klaus Brandenburg, Jorg Andra, Massimo Porro, Ignacio Moriyon Uria, Jose Leiva Leon, Guillermo Martinez de Tejada de Garaizabal, Dagmar Zweytick, Gunter Deutsch, Karl Lohner
  • Antimicrobial Peptides
    Publication number: 20090233870
    Abstract: The present invention relates to peptides with antimicrobial or endotoxin-neutralizing activity having the general formula (Xaa1)M-(Xaa2)0-Xaa3-(Xaa4)P-(Xaa5)Q-(Xaa6)M-(Xaa7)R-(Xaa8)S.
    Type: Application
    Filed: July 10, 2007
    Publication date: September 17, 2009
    Applicant: OSTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN
    Inventors: Sylvie E. Blondelle, Roman Jerala, Primoz Pristovsek, Andreja Majerle, Mateja Zorko, Bostjan Japelj, Klaus Brandenburg, Jörg Andrä, Massimo Porro, Ignacio Moriyon Uria, Jose Leiva Leon, Guillermo Martinez De Tejada De Garaizabal, Dagmar Zweytick, Gunter Deutsch, Karl Lohner